Optimal dilutions for each application to be determined by the researcher.
Application Notes:
Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
Immobilized 2019-nCoV Nucleocapsid Protein (Cat92-728) at 5.0µg/ml (100µL/well) can bind Recombinant anti-2019-nCoV NP ScFv (4A6) , the EC50 is less than 51.29ng/ml.
Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.
* VAT and and shipping costs not included. Errors and price changes excepted